CSX CORP (CSX) 30.08 -0.07 (-0.23%)
30.08 -0.07 (-0.23%)
US1264081035 - Common Stock - After market: 30.08 0 (0%)
Fundamental Rating
We assign a fundamental rating of 6 out of 10 to CSX. CSX was compared to 48 industry peers in the Road & Rail industry. Both the profitability and the financial health of CSX get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, CSX is valued expensive at the moment.
Profitability
Profitability Rating
CSX's Return On Equity of 31.71% is amongst the best of the industry. CSX does better than the industry average Return On Equity of 23.92%.
CSX's Profit Margin of 28.05% is amongst the best returns of the industry. CSX outperforms 83% of its industry peers. The industry average Profit Margin is 10.90%.
CSX has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for CSX.
CSX has a Return On Assets of 9.66%. This is comparable to the industry average of 9.66%.
VS Industry
ROA (9.66%) VS Industry: 51% outperformed.
1.57
27.69
ROE (31.71%) VS Industry: 66% outperformed.
1.75
60.21
Profit Margin (28.05%) VS Industry: 83% outperformed.
2.59
33.10
Valuation
Valuation Rating
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The Price/Earnings Ratio is 16.17, which indicates a correct valuation of CSX.
With a Forward Price/Earnings Ratio of 15.67, CSX is valued correctly.
When comparing the current price to the book value of CSX, we can conclude it is valued correctly. It is trading at 4.91 times its book value.
CSX's Price/Earning Ratio is slightly more expensive than the industry average, which is at 13.87.
Compared to an average industry price book ratio of 2.26, CSX is valued more expensive than its industry peers. 81% of the companies listed in the same industry are valued cheaper.
When comparing the Enterprise Value to EBITDA ratio of CSX to the average industry ratio of 8.04, CSX is valued more expensive than its industry peers.
VS Industry
Price/Earnings (16.17) VS Industry: 37% outperformed.
93.13
1.25
Price/Book (4.91) VS Industry: 19% outperformed.
11.19
0.26
Enterprise Value/ EBITDA (10.96) VS Industry: 33% outperformed.
44.46
3.28
Growth
Growth Rating
The Earnings Per Share has grown by an impressive 25.96% over the past year.
CSX shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 20.77% yearly.
CSX shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.06%.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Earnings Per Share is expected to grow by 9.13% on average over the next 5 years.
The Revenue has been growing slightly by 2.50% on average over the past 5 years.
Based on estimates for the next 5 years, CSX will show a small growth in Revenue. The Revenue will grow by 5.01% on average per year.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | 20.77% | 6.5% | 25.96% | 23.62% | 11.29% | 10.3% | 9.13% |
| Revenue | 2.5% | 0.73% | 22.06% | 19.97% | 8.9% | 6.84% | 5.01% |
Health
Health Rating
CSX is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.30.
When comparing the Quick Ratio to an average industry Quick Ratio of 1.27, CSX is better placed than the average industry peer to meet its short term obligations.
The Piotroski-F score of CSX is 7.00. This is a strong score and indicates good health and profitability for CSX.
CSX has a Current Ratio of 1.72. This is a normal value and indicates that CSX is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.57 indicates that CSX should not have too much problems paying its short term obligations.
CSX has an Altman-Z score of 2.48. This is not the best score and indicates that CSX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score is in line with the industry averages, which is at 2.46.
Compared to an average industry Debt to Equity Ratio of 0.53, CSX is requires more financing than its industry peers. 83% of its industry peers have a better Debt to Equity Ratio.
VS Industry
Debt/Equity (1.39) VS Industry: 17% outperformed.
5.00
0.00
Quick Ratio (1.57) VS Industry: 63% outperformed.
0.29
18.34
Current Ratio (1.72) VS Industry: 75% outperformed.
0.29
18.34
Altman-Z (2.48) VS Industry: 55% outperformed.
-20.50
21.24
Dividend
Dividend Rating
On average, the dividend of CSX grows each year by 8.34%, which is quite nice.
CSX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
CSX pays out 20.85% of its income as dividend. This is a sustainable payout ratio.
CSX has paid a dividend for at least 10 years, which is a reliable track record.
CSX has a Yearly Dividend Yield of 1.25%. Purely for dividend investing, there may be better candidates out there.
CSX's Dividend Yield is comparable with the industry average which is at 1.25.
Compared to an average S&P500 Dividend Yield of 2.41, CSX's dividend is way lower than the S&P500 average.
VS Industry
Dividend Yield (1.25%) VS Industry: 50% outperformed.
0.38
5.26
CSX CORP30.08
NASDAQ:CSX (1/27/2023, 7:01:34 PM)-0.07 (-0.23%)
| GICS Sector | Industrials | ||
| GICS IndustryGroup | Transportation | ||
| GICS Industry | Road & Rail | ||
| Earnings (Last) | 01-18 2023-01-18 | Earnings (Next) | 04-18 2023-04-18 |
| Inst Owners | 74.91% | Inst Owner Change | -0.02% |
| Ins Owners | 0.11% | Ins Owner Change | 10.86% |
| Market Cap | 63.24B | Analysts | 76.47 |
| Price Target | 34.51 (14.73%) | ||
| Dividend Yield | 1.25% | Dividend Growth | 8.34% |
| DP | 20.85% | Ex-Date | N/A |
| EPS beat(2) | 2 | Avg EPS beat(2) | 8.09% |
| Min EPS beat(2) | 2.37% | Max EPS beat(2) | 13.8% |
| EPS beat(4) | 4 | Avg EPS beat(4) | 5.01% |
| Min EPS beat(4) | 0.44% | Max EPS beat(4) | 13.8% |
| Revenue beat(2) | 2 | Avg Revenue beat(2) | 3.22% |
| Min Revenue beat(2) | 3.02% | Max Revenue beat(2) | 3.42% |
| Revenue beat(4) | 4 | Avg Revenue beat(4) | 2.71% |
| Min Revenue beat(4) | 2.15% | Max Revenue beat(4) | 3.42% |
| PT rev (1m) | 1.68% | EPS NQ rev (1m) | 0% |
| EPS NY rev (1m) | 0% | Revenue NQ rev (1m) | 0% |
| Revenue NY rev (1m) | 0% | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.17 | ||
| Fwd PE | 15.67 | ||
| P/S | 4.35 | ||
| P/FCF | 17.93 | ||
| P/OCF | 11.43 | ||
| P/B | 4.91 | ||
| P/tB | 5.13 | ||
| EV/EBITDA | 10.96 |
| EPS(TTM) | 1.86 | EY | 6.18% |
| EPS(NY) | 1.92 | Fwd EY | 6.38% |
| FCF(TTM) | 1.68 | FCFY | 5.58% |
| OCF(TTM) | 2.63 | OCFY | 8.75% |
| SpS | 6.92 | BVpS | 6.12 |
| TBVpS | 5.87 | PEG (NY) | 0.68 |
| PEG (5Y) | 0.78 | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.66% | ||
| ROE | 31.71% | ||
| ROIC | 10.99% | ||
| ROICexc | 11.7% | ||
| ROICexgc | 11.87% | ||
| OM | 39.33% | ||
| PM | 28.05% | ||
| GM | 71.63% |
| ROICexgc(3y) | 10.51% | ROICexcg growth 3Y | 0.71% |
| ROICexcg growth 5Y | 6.83% | ROICexc(3y) | 10.47% |
| ROICexc growth 3Y | 0.29% | ROICexc growth 5Y | 6.57% |
| OM growth 3Y | 1.75% | OM growth 5Y | 6.2% |
| PM growth 3Y | 3.79% | PM growth 5Y | 14.3% |
| GM growth 3Y | 0.11% | GM growth 5Y | 0.27% |
| F-Score | 7 | Asset Turnover | 0.34 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.39 | ||
| Debt/FCF | 5.12 | ||
| Debt/EBITDA | 2.51 | ||
| Cap/Depr | 136.88% | ||
| Profit Quality | 86.4% | ||
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.57 | ||
| Altman-Z | 2.48 |
| F-Score | 7 | WACC | 9.33% |
| ROIC/WACC | 1.27 | Cap/Depr(3y) | 122.18% |
| Cap/Depr(5y) | 130.55% | Profit Quality(3y) | 92.91% |
| Profit Quality(5y) | 78.49% | ||
| EPS 1Y | 25.96% | EPS 3Y | 6.5% |
| EPS 5Y | 20.77% | EPS growth Q2Q | 18.6% |
| EPS Next Y | 23.62% | EPS Next 2Y | 11.29% |
| EPS Next 3Y | 10.3% | EPS Next 5Y | 9.13% |
| Revenue growth 1Y | 22.06% | Revenue growth 3Y | 0.73% |
| Revenue growth 5Y | 2.5% | Revenue growth Q2Q | 18.32% |
| Revenue Next Year | 19.97% | Revenue Next 2Y | 8.9% |
| Revenue Next 3Y | 6.84% | Revenue Next 5Y | 5.01% |
| EBIT growth 1Y | 14.09% | EBIT growth 3Y | 2.5% |
| EBIT growth 5Y | 8.85% | EBIT Next Year | 40.71% |
| EBIT Next 3Y | 12.63% | EBIT Next 5Y | 8.92% |
| FCF growth 1Y | 37.45% | FCF growth 3Y | 4.53% |
| FCF growth 5Y | 38.76% | OCF growth 1Y | 30.51% |
| OCF growth 3Y | 3.19% | OCF growth 5Y | 10.89% |
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA